Narcan, overdose-reversing drug, is authorized for OTC gross sales by the FDA : NPR

0
505
Narcan, overdose-reversing drug, is authorized for OTC gross sales by the FDA : NPR



The opioid overdose reversal drug Narcan (proven right here on the Unitarian Universalist Congregation of Charleston in Charleston, W.Va., on Sept. 6, 2022) has been authorized for over-the-counter gross sales.

Leah Willingham/AP


conceal caption

toggle caption

Leah Willingham/AP


The opioid overdose reversal drug Narcan (proven right here on the Unitarian Universalist Congregation of Charleston in Charleston, W.Va., on Sept. 6, 2022) has been authorized for over-the-counter gross sales.

Leah Willingham/AP

The overdose-reversing drug Narcan may quickly be in the stores over-the-counter with no prescription, the Food and Drug Administration introduced Wednesday.

The FDA’s approval of the nasal spray Narcan — the model title for the drug naloxone — means the medicine might be extra extensively accessible throughout the U.S. because the nation continues to grapple with an opioid epidemic.

“Today’s motion paves the best way for the life-saving medicine to reverse an opioid overdose to be bought on to customers in locations like drug shops, comfort shops, grocery shops and gasoline stations, in addition to on-line,” the FDA mentioned in a press release.

It may take months earlier than Narcan turns into accessible over-the-counter and the price could be decided by the producer, the administration added.

The particular dose authorized for over-the-counter gross sales is the 4 milligram (mg) naloxone hydrochloride nasal spray. Other formulations and dosages of the drug would nonetheless require a prescription, the FDA mentioned.

The administration first authorized Narcan nasal spray in 2015 as a prescription drug.

LEAVE A REPLY

Please enter your comment!
Please enter your name here